Fig. 3
Subgroup analyses for the assessment of Mutsu-Senshi® by factor and P value estimated by Wilcoxon rank sum test. ESRD end-stage renal disease. *Median value was ±0 (the same as the lower side of an interquartile range)
Fig. 3 | Renal Replacement Therapy